Antimicrobial agent-31 , CAS No.A1416921

CAS: A1416921 Cat. No.: A1416921 分子式: C22H19N5O5S2 分子量: 497.55
注文可能
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
サイズ
USA
ドイツ (EU)*
価格
個数
1mg
A1416921-1mg
受注生産 · 8~12週間
Enter a quantity for the sizes you want to add.

概要

Antimicrobial agent-31 (compound 4a) is a potent antimicrobial agent. Antimicrobial agent-31 inhibits Salmonella enterica serovar Typhimurium and E.coli with MIC values of 19.24, 11.31 µg/mL, respectively.

仕様

保管条件
Store at -20°C
入荷
Ice chest + Ice pads
この製品は冷冷この冷このこの製品の運送が必要です。地上およびその他の経済サービスは利用できません。
アクションタイプ
INHIBITOR
名前と識別子
分子量
497.55

詳細データ

証明書(CoA、COO、BSE/TSEと分析図)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
ソリューション計算機
レビュー

顧客レビュー

Application Protocols

Item-specific validated applications and conditions: Not specified for this item; refer to CoA/Spec Sheet.

General guidance (class-level) for antimicrobial research assays:

  • Broth microdilution MIC: Prepare 2-fold serial dilutions in cation-adjusted Mueller–Hinton broth (bacteria) or RPMI 1640 with MOPS (fungi). Inoculate to 5×10^5 CFU/mL. Incubate per organism requirements (generally 16–20 h for many bacteria). Record MIC as lowest concentration with no visible growth; include growth and vehicle controls.
  • Time–kill assay: Expose standardized inocula to multiple concentrations (0.5–4× MIC). Sample over time, plate for CFU, and plot log10 CFU/mL vs time to infer bacteriostatic vs bactericidal effects.
  • Checkerboard synergy: Combine with a reference antimicrobial in fixed-ratio matrices. Compute FICI to assess synergy/additivity/antagonism.
  • Cytotoxicity counter-screen: Evaluate effects on mammalian cell lines (e.g., resazurin, CellTiter-Glo) to inform selectivity index in research contexts.

Always tailor conditions to your organism/assay and adhere to institutional biosafety rules. This product is for research use only.

Biological Roles

Item-specific biological targets/mechanisms: Not specified for this item; refer to CoA/Spec Sheet and SDS. No target or pathway claims are made for this specific compound.

General context (class-level, literature):

  • Antimicrobial small molecules can act on diverse microbial processes, including cell-wall biosynthesis (e.g., peptidoglycan assembly), membrane integrity, protein translation (ribosome binding), nucleic acid synthesis, folate metabolism, and redox homeostasis.
  • Resistance mechanisms (efflux, target mutation, enzymatic inactivation, biofilm protection) can influence observed potency and spectrum in assays.
  • Physicochemical properties (charge state, logD, polar surface area) govern bacterial penetration (notably Gram-negative outer membrane permeability) and can modulate observed activity independent of intrinsic target affinity.

Research use only:

  • This product is intended solely for laboratory research. It is not for use in humans or animals, and no clinical or diagnostic utility is claimed.

Best practices:

  • Use appropriate biosafety procedures for handling microbial cultures.
  • Include reference controls (e.g., standard antibiotics) to benchmark assay performance and to detect strain-specific anomalies.
Buffer Applications

Not typically applicable as a buffering reagent.

Item-specific buffer roles: Not specified for this item; refer to CoA/Spec Sheet.

General guidance (assay context):

  • While not a buffer, the compound will be used in buffered media. Select buffers compatible with your assay organism/target (e.g., Mueller–Hinton broth for bacterial MIC, RPMI 1640 with MOPS for fungal MIC) or enzyme-specific assay buffers (HEPES, Tris, phosphate) at controlled pH and ionic strength.
  • Maintain constant vehicle percentage (e.g., 0.5–1% DMSO) across dilutions to avoid confounding effects.
  • Filter-sterilize buffers and confirm pH after adding co-solvents, which may shift apparent pH.
Green Alternatives

Item-specific solvent/processing data: Not specified for this item; refer to CoA/Spec Sheet.

General greener practice for handling small-molecule screening compounds:

  • Prefer aqueous assay media with minimal organic co-solvent (≤0.5–1% DMSO) to reduce solvent burden.
  • When organic solvents are required for preparation/cleanup, consider greener options such as ethanol or 2-methyltetrahydrofuran (2-MeTHF) for synthetic steps, and water/ethanol for formulation trials where biologically compatible.
  • Consolidate operations to microvolume formats (384/1536-well plates) to minimize waste.
  • Use closed, low-evaporation plates and sealers to reduce VOC emissions.

Comparison (general, literature-based):

  • DMSO vs. Ethanol: DMSO offers superior solubility but is less preferred environmentally; ethanol is greener but may limit solubility of highly lipophilic compounds.
  • DMF/ACN vs. alternatives: DMF and acetonitrile have higher environmental/health burdens; where feasible, substitute with ethanol, 2-propanol, or water-rich mixtures for cleanup and intermediate handling (assay compatibility permitting).

Trade-offs:

  • Greener solvents can impact solubility, assay signal, and compound stability. Validate vehicle effects on microbial growth and assay enzymes before broad deployment.

Waste management:

  • Segregate halogenated from non-halogenated waste. Adopt on-plate quenching and minimal-volume dispensing to reduce hazardous waste generation.
Pharmaceutical Uses

Not for human or veterinary use. No excipient or pharmacopeial status is provided for this item.

Item-specific formulation/excipient information: Not specified for this item; refer to CoA/Spec Sheet.

General R&D context (class-level, non-clinical):

  • In preclinical research, antimicrobial tool compounds may be formulated for in vitro assays (aqueous buffers with minimal DMSO) or for exploratory in vivo studies in appropriate animal models where permitted by institutional approvals. This product is provided strictly for research use only, and no clinical application is implied.
  • Typical enabling formulations (research-stage) include aqueous vehicles with solubilizers (e.g., Captisol, PEG-400, polysorbates) or pH-adjusted salt forms to enhance solubility; compatibility must be verified for each scaffold.
  • For stability-indicating studies, monitor potency and purity under relevant storage/assay conditions (LC–MS/HPLC) and evaluate adsorption to plastics or serum protein binding as needed.
Physical Properties

Item-specific values (specifications):

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point (MP): Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point (BP): Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • LogP/logD: Not specified for this item; refer to CoA/Spec Sheet.
  • pKa: Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive index: Not applicable/unknown for a solid; if liquid, not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.

General guidance (literature/class-level; not specific to this item):

  • Small-molecule antimicrobials used in screening are frequently supplied as dry powders or as DMSO solutions. Many exhibit good solubility in anhydrous DMSO (10–50 mM typical screening stocks), with aqueous compatibility enhanced by co-solvents (1–5% DMSO, 0.1–0.5% v/v surfactant if permitted by assay).
  • Ionizable compounds may show dramatically different solubility across pH; determine pKa (if available) to choose appropriate buffer (e.g., acidic for basic amines; basic for acids) while maintaining assay viability.
  • Hygroscopic or light-sensitive behavior varies by scaffold; verify on the CoA. If uncertain, protect from moisture and light and work quickly at room temperature.

Practical notes:

  • Confirm solid state (free base vs. salt) before weighing. Adjust molarity for counterions.
  • Filter sterilization of working solutions (0.22 µm) is generally acceptable unless compound binds to membranes; pre-rinse filter with solvent where needed.
Quality and Grades

Item-specific grade/purity:

  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

Interpreting grades (general guidance):

  • Library/screening-grade small molecules are typically provided at high chemical purity (often ≥95% by HPLC) to ensure reliable biological readouts, but exact thresholds vary by supplier and batch; consult the CoA.
  • If LC–MS/HPLC traces are provided, confirm a single dominant peak at the stated wavelength(s). Verify mass accuracy and adduct pattern.
  • Salt form and residual solvents can influence apparent purity and assay behavior. Review Karl Fischer (water), residual solvent, and counterion data where available.

Stabilizers/inhibitors:

  • Not specified for this item; refer to CoA/Spec Sheet. If a stabilizer is present (e.g., BHT, ascorbate), document it, as it may interfere with redox-sensitive assays.

Batch-to-batch considerations:

  • Record lot number and ensure the same lot is used across replicate studies.
  • For hit-confirmation campaigns, re-purchase or re-purify and cross-check identity by NMR/HRMS when feasible.

Documentation:

  • The CoA/Spec Sheet is the authoritative source for purity, analytical methods, and acceptance criteria for this specific item.
Reaction and Applications

Item-specific synthetic/reaction roles: This product is positioned as a research antimicrobial screening compound rather than a general synthetic reagent. No specific reaction applications are provided for this item; refer to CoA/Spec Sheet for any available synthetic lineage.

General applications in research (class-level):

  • Phenotypic antimicrobial screening: evaluate growth inhibition or kill curves against bacterial or fungal strains in microdilution assays (e.g., MIC determination per CLSI/EUCAST methodologies). Ensure appropriate vehicle controls and inoculum verification.
  • Target-based assays: test against purified microbial enzymes or pathways (e.g., cell-wall biosynthesis, protein synthesis, DNA replication) as appropriate to the research scope.
  • Mechanism-of-action (MOA) exploration: time-kill kinetics, synergy studies (checkerboard assays), post-antibiotic effects, resistance selection/whole-genome sequencing to suggest MOA.
  • ADME profiling (in vitro): solubility, permeability (PAMPA/MDCK), microsomal stability, and plasma protein binding to inform lead optimization, where permitted.

Practical tips:

  • Pre-screen for aggregation (detergent sensitivity, DLS, or variation with BSA) to reduce false positives.
  • Confirm activity with fresh stocks and independent lots to exclude decomposition artifacts.
  • For combination studies, use fractional inhibitory concentration index (FICI) methods and fixed-ratio designs.
Reaction Conditions

This product is intended as a research screening compound rather than a general synthetic reagent; no specific chemical reaction conditions apply to its use.

Item-specific reaction guidance: Not specified for this item; refer to CoA/Spec Sheet.

General assay setup considerations (class-level, practical):

  • Stock preparation: dissolve accurately weighed compound in anhydrous DMSO to a defined concentration (e.g., 10–50 mM), vortex and, if needed, gently warm (≤37°C) or sonicate briefly. Filter if required by the assay and compound stability allows.
  • Working dilutions: prepare serial dilutions in assay medium keeping vehicle constant. Equilibrate to assay temperature prior to dosing.
  • Adsorption/aggregation: mitigate with low-binding plastics and optional non-ionic surfactant (if assay-tolerant). Confirm absence of colloidal aggregation artifacts (detergent sensitivity or DLS).
  • Stability: minimize light and moisture exposure if sensitivity is suspected; confirm by re-injecting on HPLC after assay window.

Note: For actual synthetic transformations using this molecule (e.g., as a reference intermediate), consult structure-specific literature/protocols once the chemical identity is available.

Safety and Handling

Item-specific hazard data:

  • GHS Classification: Not specified for this item; refer to SDS.
  • Signal Word: Not specified for this item; refer to SDS.
  • Hazard (H) statements: Not specified for this item; refer to SDS.
  • Pictograms: Not specified for this item; refer to SDS.

General laboratory safety (class-level guidance):

  • Handle all unknown bioactive small molecules as potentially harmful. Avoid inhalation, ingestion, and skin/eye contact. Work in a chemical fume hood with appropriate ventilation.
  • Personal protective equipment (PPE): lab coat, safety glasses or splash goggles, and suitable chemical-resistant gloves (e.g., nitrile). For weighing fine powders, consider a balance enclosure and antistatic measures.
  • Avoid generating dust/aerosols. For DMSO stocks, prevent skin contact; DMSO can facilitate dermal absorption of solutes.
  • Storage incompatibilities: keep away from strong oxidizers/reductants and reactive bases/acids until the exact functional groups are known. Segregate from food and incompatible chemicals.
  • First aid (overview; defer to SDS): in case of skin/eye contact, rinse with water for at least 15 minutes; remove contaminated clothing. If inhaled, move to fresh air. If ingested, rinse mouth and seek medical attention. Always provide the SDS to responders.
  • Waste: Collect in organic halogenated/non-halogenated waste as appropriate for the working solvent. Do not discharge to drains.

Special risks:

  • Some antimicrobial chemotypes may be sensitizers or cytotoxic. Use closed microplate formats and sealed reservoirs when running phenotypic assays. Always consult the batch-specific SDS for authoritative safety guidance.
Solvent Selection

Item-specific solubility: Not specified for this item; refer to CoA/Spec Sheet.

General solvent strategy for small-molecule antimicrobials (class-level guidance):

  • Primary stock solvent: anhydrous DMSO is preferred for broad solubilization and assay compatibility. Prepare concentrated stocks (e.g., 10–50 mM) and store aliquoted at −20°C to minimize freeze–thaw.
  • Aqueous working solutions: dilute stocks into assay buffer with final DMSO typically ≤0.5–1% v/v to maintain cell viability and enzyme activity. Include low-binding plasticware to reduce adsorption.
  • Alternative co-solvents (as assay permits): DMF, ethanol, or PEG-400 can assist with challenging scaffolds; assess assay tolerance and vehicle controls.
  • Buffers: choose pH with awareness of ionization (if pKa known). Use HEPES or phosphate buffers for many cell-based or enzyme assays, ensuring osmolarity and ionic strength remain within physiological ranges.
  • Surfactants: non-ionic surfactants (e.g., 0.01–0.05% Tween-80 or Pluronic F-68) can reduce aggregation/false positives in phenotypic screens.

Comparison snapshot (general):

  • DMSO: highest solvating power; excellent stability; consider dermal absorption risk.
  • Ethanol: volatile, biologically tolerated at low %; poorer for very lipophilic compounds.
  • DMF: strong solvent but more cytotoxic; limit final concentration.
  • Aqueous only: ideal for charged/salt forms; may require pH adjustment and gentle warming/sonication.
Storage and Reconstitution

Item-specific conditions (from Product Data):

  • Storage Conditions: Store at -20°C.
  • Shipped In: Ice chest + Ice pads.

Additional item-specific details:

  • Appearance, stabilizers, hydration state, and exact solubility: Not specified for this item; refer to CoA/Spec Sheet.

General best practices (class-level):

  • Upon receipt, place immediately at −20°C. If hygroscopic or light-sensitive behavior is suspected, store in a desiccator and protect from light (amber vials/foil) until confirmed by the CoA.
  • Reconstitution: Prepare a concentrated stock in anhydrous DMSO (e.g., 10–50 mM) unless the CoA specifies another solvent. Vortex thoroughly; gentle warming (≤37°C) and brief sonication may aid dissolution. Record exact solvent and concentration in LIMS.
  • Aliquoting: Dispense single-use aliquots to avoid repeated freeze–thaw. For DMSO stocks, freeze at −20°C; minimize air headspace to reduce oxidation/hydrolysis risk.
  • Thawing: Allow vials to equilibrate to room temperature before opening to prevent moisture condensation. Mix before use.
  • Stability monitoring: Periodically check by HPLC/LC–MS for degradation under storage/assay conditions.

Research Use Note:

  • For research use only. Not for human or veterinary use.
Structure and Identity

Item-specific identifiers (from Product Data):

  • SKU: A1416921
  • Product Name: Antimicrobial agent-31
  • CAS: A1416921 (catalogue identifier)
  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.

Structural description:

  • Item-specific structural features (ring systems, heteroatoms, stereochemistry): Not specified for this item; refer to CoA/Spec Sheet.

General notes (class-level, literature):

  • “Antimicrobial agent-31” indicates a small-molecule research compound curated for antimicrobial screening workflows within small-molecule/compound libraries.
  • Antimicrobial chemotypes commonly include heteroaromatic scaffolds, cationic amphiphiles, peptide-mimetics, or cell-wall–active motifs; however, no structural assumptions should be made for this specific item in the absence of a provided structure.
  • If structure is provided on the CoA/Spec Sheet, record the exact stereochemistry, functional groups (e.g., amide, amine, heteroaryl), and any salts (HCl, TFA) for accurate molarity calculations.

Best practice:

  • Use the exact molecular weight and salt form from the CoA when preparing stock solutions.
  • Link any internal LIMS records to the specific batch’s InChIKey and SMILES (when available) to avoid ambiguity across analog series.
Synthetic Utility

Item-specific use as a synthetic reagent/building block: Not specified for this item; refer to CoA/Spec Sheet.

General perspective (class-level):

  • Compounds labeled as “antimicrobial agent” in screening libraries are typically end-point bioactive molecules rather than building blocks; direct use as reagents in synthetic transformations is uncommon.
  • Nevertheless, once structure is known, medicinal chemistry workflows may employ the compound as a reference standard, a precursor for semisynthetic analogs, or a handle for probe development (e.g., biotinylation/photocrosslinkers) to study target engagement.
  • If functional groups allow (e.g., amines, carboxylic acids, aryl halides), analog synthesis via amide coupling, SNAr, cross-coupling (Suzuki, Buchwald–Hartwig), or late-stage diversification may be feasible for SAR campaigns.

Recommendations:

  • Obtain the structural and analytical data (NMR, HRMS, HPLC) from the CoA/Spec Sheet before planning derivatization.
  • Assess IP/freedom-to-operate if the compound maps to known scaffolds.
Target Specificity

Item-specific biological target, selectivity, and spectrum: Not specified for this item; refer to CoA/Spec Sheet.

General remarks (class-level):

  • Antimicrobial small molecules may exhibit narrow or broad spectra and may act on cell wall, membrane, or intracellular targets. Without target disclosure, claims about specificity cannot be made for this product.

Recommendation:

  • Determine spectrum and potential target via comparative MIC panels, synergy/antagonism assays, resistance mapping, and biochemical target assays where appropriate.

よくある質問

How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is A1416921, the molecular formula is C22H19N5O5S2, and the molecular weight is 497.55 g/mol.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.